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。研究自的
近年の免疫学の進歩は目覚しく、生体には自然免疫と獲得免疫が存在し、それぞれ相関しなが
』ら生体訪御に役立っているG しかし、この免疫機構の中で、種々の原因により生理的バランスが
崩れると免疫疾患と呼ばれる一連の疾患が発症するむ
当研究室では、免疫疾患のうち、特にアレノレギーと自己免疫疾患に焦点を当て、治療薬の基礎
的検索と発症の分子自号機構の解明を試みる。
。研究概要
I ）アレルギーおよび自己免疫疾患発症機淳の紹胞および分子レベルでの研究
研究室で開発した臨床症状を反映した実験モテ、ルを用い、遺伝子工学的手法、分子生物学的手法
および薬理学的手法を駆使して、発症に必要な分子および細胞を検索する。
むアレルギーおよび自己免疫疾患治療薬検索の基礎的検討
前述の実験モデノレを用い、天然物あるいは合成化合物の中から存効物質を検索し、医薬品として
の可能性を検討する。
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〈〉原著論文。KawakamiYらInagakiN .,SaleιArda孟aniS., KiをauraJ叫 TanakaH.，関agaoK., Kawakami 
Y., Xiao W., Nagai E咋 CroftM~， and Kawai法 miT. :Regulation of denderitic cell maturation 
・ and function by Bruton's tyrosine kinase via IL圃10and Stat3. Proc Natl Acad Sci USA吋
103(1): 153-158争2006.
Abstract: Btk plays crucial roles in the differentiation and activation of B and myeloid cels. Despite 
drastic reductions of other lg isotypes, paradoxically high IgE responses have been known in btk mutant 
mice. Here we show thatるtk（ー／ー）dendritic cells exhiもita more mature pheno守peand a s仕ongerin vitro 
and in vivo T cell-stimulatory ability than wild-type cels. Increased IgE responses were induced句f
adoptive transfer of btk(-/-) dendritic cells into mice. Consistent with the stronger T cell-stimulatory 
ability ofbtk（－／うdendriticcells，ちtk（ー／ー）mice exhibited enhanced inflammation in Th2-driven asthma and 
Thi-driven contact sensitivity experiments. These negative regulato巧ffunctions of Btk in dendritic cells 
appear ぬるemediated mainly through autocrine secretion of IL-10 ～and subsequent activation of Stat3. 
2) Oki T吋 KitauraJ., Eto 豆.，Lu Y., Maeda-Yamamoto M咋 InagakiN., Nagai H., Yamanishi Y., 
Na主ajinaH叫 KumagaiH., and Kitamura T. :Integrin α11 b (}3 induces白eadhesion and 
ac託、rationof mast cellsをhroughinteraction with fibrinogen. :The Journal of Immunology.吋
176: 52-60, 2006. 
Abstract: Integrin alphaIIbラawell-known marker of megakaryocyte-platelet lineageラhasbeen recently 
recognized on hemopoietic progenitors. We now demonstrate that integrin alphaIIbちeta3is highly 
expressed on mouse and human mast cells including mouse bone marrow-derived mast cels, peritoneal 
mast cellsラandhuman cord blood-derived mast cellsラandthat its binding to extracellular matrix proteins 
leads to enhancement of biologicalおnctionsof mast cells in concert with various stimuli. With exposure 
to various stimuliラincludingcross-linking of F cepsilonまIand stem cel factor, mast cells adhered to 
extracellular matrix proteins such as fibrinogen and von ・wmebrand factor in an integrin 
alphaIIbbeta3-dependent manner. In addition, theるindingof mast cells to fibrinogen enhanced 
proliferation, cytokine production, and migration and induced uptake of soluble fibrinogen in response to 
stem cel factor stimulationラ implicatingintegrin alphaIIbbeta3 in a variety of mast cel functions. In 
conclusion, mouse and human mast cells express functional integrin alphaIIbbeta3. 
3) Kimata M., Ishizaki M., Tana匙aH., Nagai H., and Inagaki N. :Production of matrix 
metalloproteinases in human culu組問dmast cells: involvement of protein kinase c-mi鈎gen
activated pro主einkinase kinase圃 xtracellularsignalregulated kinase pathway. Allergology 
International., 55(1): 67-76, 2006. 
Abstract: BACKGROUND: Matrix metalloproteinases (MMPs) have been reported to play crucial roles 
in the migration of inflammatory cells through basement membrane components. To confirm the role of 
mast cells as a source of MMPsラweinvestigated the production of MMP and its pathway in human 
cultured mast cells (HCMC). We also investigated the production of tissue inhibitors ofmetall6proteinase 
(TIMPs). METHODS: HCMC was stimulated with phorbor 12-miristate 13-acetate (PMA) and/or 
calcium ionophore A23187 (A23187), and the resulting MMP production was evaluated by gelatin 
zymography and western blotting. Expression of MMP and TIMP mRNA was also examined. 
Granulocyte macrophage-colony stimulating factor (GM-CSP) was measured by ELISA and activation of 
extracellular signal-regulated kinase (ER玄）was evaluated by western blotting. RESじLTS:We detected 
the de novo synthesis ofMMP-9 in HCMC after stimulation with PMA and found that the synthesis was 
mediated through protein kinase C・mitogen activated protein kinase kinase (MEK)-ERK pathway. The 
MMP-9 production induced by PMA was suppressed by simultaneous treatment with A23187ラwhereas
GM-CSF production was potentiated. We also detected the expression of mRNA for membrane-type 1 
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(MTl}MMP, TIMP-1 and TIMP-2 a主erstimulation with PMA. Glucocorticoids and flavonoids inhibited 
MMP-9 production, and TIMPs and MMP inhibitors inhibited the gelatinolytic activity of mast 
cell-derived MMP-9. Furthermoreラ phenylmethylsulfonylfluorideラ aprotease inhibitorラ inhibitedthe 
conversion企ompr・oMMP-9to active MMP-9. CONCLUSIONS: These results suggest that the human 
mast cel is a leading member of MMP productionラ andthe production, activation and activi匂rare 
controllable by pharmacological agents. 
4) Oida Y.雪Ki匂ichiK., Na孟ayamaH.,IをoY., Fujimoto Y吋 ShimazawaM., Nagai H., and Hara 
H. :Rifampicin sttenuates the MPTP-induced neurotoxicity in mouse brain. Brain Research, 
1082: 196圃204,2006. 
Abstract: Rifampicinラ anantibacterial drugラ ishighly effective in theなeatmentof tuberculosis and 
leprosy.まecently,it has been reported to have neuroprotective effects in in vitro and in vivo models. This 
study was designed to elucidate its neuroprotective effects against 
1-methyl-4-phenyl-lム3,6-tetrahydropyridine(MPTP)-induced neurotoxicity (known as an in vivo 
mouse model of Parkinson’s disease). Mice were injected intraperitoneally (i.p.) with沼PτP(10 mg/kg) 
four times at 1-h intervals, and brains were analyzed 3 or 7 days later. Rifampicin at 20 mg/kg (i.p., twice) 
had protective effects against MPτP-induced neuronal damage (immunohistochemical changes _in 
tyrosine hydroxy lase) in both the substantia nigra and striatum. Rifam予icinalso protected against the 
MPTP-induced depletions of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), and homovanillic 
acid (HVA) in the striatum. The maximal concentrations of rifampicin between 30 and 240 min after a 
single rifampicin injection (20 mg/kg, i.p.) were 2.6 μM (at 30 min) in plasma and 0. 77μM (at 60温in)in 
stria tum. Nextラ theeffects of rifampicin on oxidative stress [lipid peroxidation in mouseちrain
homogenates and free radical-scavenging activity against diphenyl-p-picrylhydrazyl (DPP耳）］ we民
evaluated to clarifシtheunderlying mechanism. At 1 μM or血ore,rifampicin significantly inhibited both 
lipid peroxidation in the stratum and企eeradical production. These findings suggest that in mice, 
rifampicin can reach brain tissues at concentrations sufficient to attenuate MPTP-induced 
neurodegeneration in the nigrostriatal dopaminergic neuronal pathway, and that at inhibitory effect 
against oxidative stress may be partly responsible for its observed neuroprotective effects. 
5) Ta主ayamaGラArimaK., 1匂najiT., Toda S., Tanaka H., Shoji S., Andrew N. J. McKenzie., 
Nagai H., Hotokebuchi T., and Izuhara K. :Periostin: A novel componenまofsubepithelial 
fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J. Allergy Clin. 
Immunol., 118 (1): 98-104ラ2006.
Abstract: BACKGROUND: Subepithelial fibrosis is a cardinal feature ofちronchiaiasthma. Collagen Iラ
IIラandV; fibronectin; and tenascin-C are deposited in the lamina reticularis. Extensive evidence supports , 
the pivotal role of IL-4 and IL-13 in subepithelial fibrosis; howeverラtheprecise mechanism remains 
unclear. We have previously identified the POSTN gene encoding periostin as an IL-4/IL-13-inducible 
gene in bronchial epithelial cels. Periostin is thought to be an adhesion molecule because it possesses 4 
fasciclin I domains. OBJECTIVE: We explore the possibili匂fthat periostin is involved in subepithelial 
fibrosis in bronchial asthma. METHODS: We analyzed induction of periostin in lung fibroblasts by IL-4 
or IL-13. We next analyzed expression of periostin in patients with asthma and in _ovalbumin-sensitized 
and ovalbumin-inhaled mice. Furthermore, we examined the binding ability of periostin to other 
extracellular matrix proteins. RESULTS: Both IL-4 and IL-13 induced secretion of periostin in lung 
fibroblasts independently of TGF-beta. Periostin colocalized with other extracellular matrix proteins 
involved in subepithelial fibrosis in both asthma patients and ovalbumin-sensitized and 
ovalbumin-inhaled wild-type miceラbutnot in either IL-4 or IL.,13 knockout mice. Periostin had an ability 
to bind to fibronectinラtenascin-C,collagen V, and periostin.itsel王CONCLUSION:Periostin secreted by 
lung fibroblasts in response to IL-4 and/or IL-13 is a novel component of subepithelial fibrosis in 
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ちronchialasthma. Periostin may contribute to this process by binding to other extracellular matrix 
proteins. CLilゼCALIMPLICATIONS: Periostin induced by IL-4/IL・13shows promise in inhibiting 
subepithelial fi討osisin bronchial asthma. 
6) Inagaki N .,Shiraishi関門 lgetaK., Itoh T., Chikumoto T叫 NagaoM., John Fan Kim., and 
Nagai H. :Inhibition of scratching behavior associated with allergic dermatitis in mice by 
tacrolimus, but noをbydexamethasone. European Journal of Pharmacology.事546:189-196, 
2006. 
Abstract: Itching is the most important problem in many allergic and inflammatory skin diseases 
especially in atopic dermatitis. However, animal models for allergic dermatitis useful for the study of 
itching have rarely been established. We established a mouse allergic dermatitis model involving frequent 
scratching behavior by repeated painting with 2,4-dinitrofluorobenzene (DNFB) acetone solution onto 
the mouse skin, and comparatively examined the effects of tacrolimus and dexamethasone on the 
dermatitis and associated scratching behavior. Repeated DNFB painting caused typical dermatitis 
accompaniedちyelevated serum immunoglobulin E (IgE) and frequent scratching behavior. An apparent 
thickening of the epidermis and dermisラandthe significant accumulation of inflammatory cells were 
observed. Increased interferon (IFN)-gamma mRNA expression and the induction of interleukin (IL)-4 
and IL-5 mRNA expression were also observed in the skin lesion.τhe scratching behavior was inhibited 
by dibucaine and naloxone. Although tacrolimus reduced the increased ex予ressionof IFN-gamma and 
IL-4 mRNAラ dexamethasonepotently depressed that of IFN-gammaラ IL-4and IL-5 mRNA. 
Dexamethasone inhibited the accumulation of lymphocytes and eosinophilsラalthoughtacrolimus did not. 
Both drugs failed to inhibit the elevation of serum IgE levels. Tacrolimus significantly inhibited the 
scratching behavior that was associated with the inhibition of nerve fiber extension into the epidermisラ
whereas dexamethasone failed to have any effect. The mouse dermatitis model seems to be beneficial for 
the study of itching associated with allergic dermatitisラsuchas atopic dermatitis, and tacrolimus seems to 
exhibit an anti-itch effect through the inhibition of nerve fiber extension at least in part. 
7) Al五abaneH., Murata M巧 KubotaM叫 TakashimaE., Tanaka H., Inagaki N咋 HoribaM., and 
持agaiH. :Effects of salmeterol xinafoate and fluticasone propionate on immunological 
activa主ionof human cultured mast cels. Allergology International事55(4):387圃393ラ2006.
Abs臼・acを： BACKGIミOUND:The clinical efficacy of combination therapy comprising a long acting 
beta(2)-agonist (LABA) and corticosteroid is widely recognized for the treatment of adult asthma. Here 
we examine the effect of salmeterol xinafoate (SX) and fluticasone propionate (FP) alone and in 
combination on the immunological activation of human cultured mast cells （ヨCMC)invitro. METHODS: 
HCMC were passively sensitized with IgE antiちodyand then activated by challenging with anti-IgE 
antiるody.The effect of drugs on the activation of mast cells was examined by measuring the amount of 
released chemical mediators (histamineラ leukotrienes(Lτ） and prostaglandin D(2) (PGD(2))) and 
granulocyte macrophage colony stimulating factor (GI¥ιCSF). RESULTS：τhe release of each chemical 
mediator was inhibited by 10-9-10-8M SX but not by 10-10・10-7M FP. The production of GM-CSF was 
inhibited by a concentration of 10-8M in both drugs .and the inhibition was aug出entedちycombined 
訂eatmentwith 10-1 lM of each drug. CONCLUSIONS: The immunological release of chemical 
mediators (histamine, LT, PGD(2)) from HCMC was inhibited by SX but not by FP. SX and FP inhibited 
the production of GM-CSF by HCMC and both drug showed synergistic inhibition in the production of 
GI¥ιCSF. 
8) Gao Xinkun., Tanaka 誼.， Inagaki N ., Teramachi H叫 Tsuchiya I：事 and Nagai 
H. :Immunopharmacological studies on the effects of Juzentaihoto and Hochuekkito on 
experimental autoimmune encephalomyelitis in ra低 J.Trad. Med., 23: 196-202, 2006. 
Abstract: Experimental autoimmune encephalomyelitis (EAE) is a prototype experimental model for 
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human multiple sclerosis (MS). This study was conducted to research the effects of Juzentaihoto and 
Hochuekkito on the onset and development of EAE. Both Juzentaihoto and Hochuekkito suppressed the 
onset and development of EAE. Suppressive mechanisms ofちothKampo medicines are mainly based on 
the immunosuppressive and anti-inflammatory activi守. In addition, Hochuekkito showed 
immunomodulating activity in the central nervous syste担.These findings will contribute to consider a 
new therapy of human MS. 
〈〉総説
1) Nagai H.ラTeramachiH.ラTuchiyaT. :Recent advances in the development of anti-allergic drugs. 
Allergology Internationalラ 55(1）ラ35-42ラ2006.
2) 田中宏幸，稲垣直樹，永井i専弐：脂質メディエーターと気管支端息．呼吸， 25:944-949ラ
2006. 
3) 永井静弐：アレルギー性炎症とりモデリング．耳鼻免疫アレノレギー， 24:5-7ラ2006.
。学会報告 〈＊：持別講演、シンポジウム、ワークショッブ等〉
1) Nagai H.ラ InagakiN., Tanaka H. :Role of IL-5ラ eosinophilsand TGF－~l in allergen-induced 
註1subepithelial fibrosis in mice. Collegium International Allergologicum 26' Symposiumラ2006ラ
5.5-10ラMalta.
2) 永井博弐：大森健守：アレルギ一治療薬の将来展望－開発の現場から．第 18回日本ア
レノレギー学会春季臨床大会， 2006ラ5.30-6.1ラ東京．
3) 永井博二丈：アレルギー性炎症の免疫薬理学的解析．第36回日本皮膚アレルギー学会・
第 31回日本接触長膚炎学会合同学術大会， 2006ラ7.15-16，兵庫．
4) 永井博二丈：和漢薬からの抗アレルギー薬開発研究の試み．第23回和漢医薬学会大会，
2006ラ8.26・27ラ岐阜．
5) 永井博二℃：アレルギー疾患治療標的としての詣質メディエーター．第 56回日本アレルギ
一学会秋季学術大会， 2006ラ11.2-4ラ東京．
〈〉その他
2) 
4) 
永井博二毛：女性の免疫力、男性の免疫力．名古屋栄中日文化センタ一大学提携講座， 2006,
7ヲ愛知．
Nagai H :The classification of ~2-agonists based on intrinsic efficacy. Meptin Expert Conferenceラ
2006ラ8ラ東京
Nagai H :The possible role of prostaglandins in allergic inflammation. AR Forum 2006ラ2006,8ラ
東京．
永井博弐：基礎の面から見た抗アレノレギー薬の併用療法．アレノレギー性鼻炎治療研究会
entry第6田セミナー， 2006,10ラ東京．
永井博二に：アレルギーのモデル研究．フォーラム 2006衛生薬学・環境トキシコロジー，
2006ラ10ヲ東京．
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